Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
DULUTH, Ga, and LONDON, Aug. 27, 2026 /PRNewswire/ -- Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of new HealthTech guidance by the United Kingdom's National Institute for Health and Care
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire

In the news release, UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life's VitaSmart™ Hypothermic…

Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and…

Clinical data show meaningful increases in organ utilization, unlocking new transplant supply in a market constrained by donor…

New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life's VitaSmart™ Hypothermic…

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically…

GOTHENBURG, SE / ACCESS Newswire / August 3, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the…